Related Experiment Video
Updated: Aug 7, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters
A Di Pietro1, G Conseil, J M Pérez-Victoria
1Institut de Biologie et Chimie des Protéines, UMR 5086 CNRS/Université Claude Bernard-Lyon I, Passage du Vercors, Lyon, France.
Abstract:
Cancer cell resistance to chemotherapy is often mediated by overexpression of P-glycoprotein, a plasma membrane ABC (ATP-binding cassette) transporter which extrudes cytotoxic drugs at the expense of ATP hydrolysis. P-glycoprotein (ABCB1, according to the human gene nomenclature committee) consists of two homologous halves each containing a transmembrane domain (TMD) involved in drug binding and efflux, and a cytosolic nucleotide-binding domain (NBD) involved in ATP binding and hydrolysis, with an overall (TMD-NBD)2 domain topology. Homologous ABC multidrug transporters, from the same ABCB family, are found in many species such as Plasmodiumfalciparum and Leishmania spp. protozoa, where they induce resistance to antiparasitic drugs. In yeasts, some ABC transporters involved in resistance to fungicides, such as Saccharomyces cerevisiae Pdr5p and Snq2p, display a different (NBD-TMD)2 domain topology and are classified in another family, ABCG. Much effort has been spent to modulate multidrug resistance in the different species by using specific inhibitors, but generally with little success due to additional cellular targets and/or extrusion of the potential inhibitors. This review shows that due to similarities in function and maybe in three-dimensional organization of the different transporters, common potential modulators have been found. An in vitro 'rational screening' was performed among the large flavonoid family using a four-step procedure: (i) direct binding to purified recombinant cytosolic NBD and/or full-length transporter, (ii) inhibition of ATP hydrolysis and energy-dependent drug interaction with transporter-enriched membranes, (iii) inhibition of cell transporter activity monitored by flow cytometry and (iv) chemosensitization of cell growth. The results indicate that prenylated flavonoids bind with high affinity, and strongly inhibit drug interaction and nucleotide hydrolysis. As such, they constitute promising potential modulators of multidrug resistance.
Insights
Prenylated flavonoids show promise in overcoming cancer multidrug resistance by inhibiting P-glycoprotein (ABCB1) activity. These compounds effectively block drug efflux and ATP hydrolysis, offering a new strategy against chemotherapy resistance.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Cancer chemotherapy resistance is frequently linked to P-glycoprotein (P-gp/ABCB1) overexpression.
- P-gp, an ATP-binding cassette transporter, actively extrudes cytotoxic drugs from cancer cells.
- Modulating P-gp activity is a key challenge in improving cancer treatment efficacy.
Purpose of the Study:
- To identify and evaluate potential modulators of P-glycoprotein-mediated multidrug resistance.
- To investigate the efficacy of flavonoids as inhibitors of P-gp function.
- To explore novel strategies for overcoming chemotherapy resistance in cancer.
Main Methods:
- In vitro rational screening of the flavonoid family.
- Assessing direct binding to purified P-gp NBD and full-length transporter.
- Measuring inhibition of ATP hydrolysis and drug interaction in transporter-enriched membranes.
- Flow cytometry analysis of P-gp activity and cell growth chemosensitization.
Main Results:
- Prenylated flavonoids demonstrated high-affinity binding to P-gp.
- These compounds significantly inhibited drug efflux and P-gp's ATP hydrolysis.
- Prenylated flavonoids effectively sensitized cancer cells to chemotherapeutic drugs.
Conclusions:
- Prenylated flavonoids are potent inhibitors of P-glycoprotein.
- They represent promising therapeutic agents for overcoming multidrug resistance in cancer.
- Targeting P-gp with specific modulators like prenylated flavonoids could enhance chemotherapy effectiveness.
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

